Ashwin Ashok Naik

Ashwin Ashok Naik

Auto-generated profile, based on publicly available information

Ashwin Ashok Naik

Disease Biology Laboratory, Department of Biosciences, Sri Sathya Sai Institute of Higher Learning, Anantapur, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SBSai Krishna S B
Sai Krishna S B
SPSujith Kumar Pulukool
Sujith Kumar Pulukool
SPSai Sanwid Pradhan
Sai Sanwid Pradhan
SRSaiswaroop R.
Saiswaroop R.
ANAshwin Ashok Naik
Ashwin Ashok Naik
VSVenketesh Sivaramakrishnan
Venketesh Sivaramakrishnan
Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease leading to inflammation, cartilage cell death, synoviocyte proliferation, and increased and impaired differentiation of osteoclasts and osteoblasts leading to joint erosions and deformities. Transcriptomics, proteomics, and metabolomics datasets were analyzed to identify the critical pathways that drive the RA pathophysiology. Single nucleotide polymorphisms (SNPs) associated with RA were analyzed for the functional implications, clinical outcomes, and blood parameters later validated by literature. SNPs associated with RA were grouped into pathways that drive the immune response and cytokine production. Further gene set enrichment analysis (GSEA) was performed on gene expression omnibus (GEO) data sets of peripheral blood mononuclear cells (PBMCs), synovial macrophages, and synovial biopsies from RA patients showed enrichment of Th1, Th2, Th17 differentiation, viral and bacterial infections, metabolic signalling and immunological pathways with potential implications for RA. The proteomics data analysis presented pathways with genes involved in immunological signaling and metabolic pathways, including vitamin B12 and folate metabolism. Metabolomics datasets analysis showed significant pathways like amino-acyl tRNA biosynthesis, metabolism of amino acids (arginine, alanine aspartate, glutamate, glutamine, phenylalanine, and tryptophan), and nucleotide metabolism. Furthermore, our commonality analysis of multi-omics datasets identified common pathways with potential implications for joint remodeling in RA. Disease-modifying anti-rheumatic drugs (DMARDs) and biologics treatments were found to modulate many of the pathways that were deregulated in RA. Overall, our analysis identified molecular signatures associated with the observed symptoms, joint erosions, potential biomarkers, and therapeutic targets in RA. Communicated by Ramaswamy H. Sarma

6 March 2026 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
SRSaiswaroop Rajaratnam
Saiswaroop Rajaratnam
VDV. M. Datta Darshan
V. M. Datta Darshan
ANAshwin Ashok Naik
Ashwin Ashok Naik
SBSai Krishna S B
Sai Krishna S B
DKDr. Vishnu Kannan
Dr. Vishnu Kannan
VSVenketesh Sivaramakrishnan
Venketesh Sivaramakrishnan